Adapalene
Back to searchMolecule Structure
Scientific Name
Adapalene
Description of the Drug
Adapalene is a third-generation topical retinoid with anti-comedogenic, comedolytic, and anti-inflammatory properties used to treat acne vulgaris in adolescents and adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00210
http://www.drugbank.ca/drugs/DB00210
Brand Name(s)
Adapalene, Differin
Company Owner(s)
Glenmark Generics Inc Usa, Taro Pharmaceuticals Inc, Aleor Dermaceuticals Ltd, Fougera Pharmaceuticals Inc, Actavis Mid Atlantic Llc, Encube Ethicals Pvt Ltd, P And L Development Llc, Taro Pharmaceuticals Usa Inc, Call Inc Dba Rochester Pharmaceuticals, Padagis Israel Pharmaceuticals Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Retinoic acid receptor | PROTEIN FAMILY | AGONIST | CHEMBL2363069 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2747 | |
PharmGKB | PA448047 | |
Human Metabolome Database | HMDB0014355 | |
DrugBank | DB00210 | |
PubChem: Thomson Pharma | 14757761 | |
PubChem | 60164 | |
Mcule | MCULE-5017789384 | |
LINCS | LSM-37048 | |
BindingDB | 50048280 | |
EPA CompTox Dashboard | DTXSID5046481 | |
DrugCentral | 87 | |
ChemicalBook | CB6771245 | |
Guide to Pharmacology | 5429 | |
rxnorm | DIFFERIN | ADAPALENE |
ChEBI | 31174 | |
ZINC | ZINC000003784182 |